Severe inherited retinal diseases, such as retinitis pigmentosa and Leber congenital amaurosis, are caused by mutations in genes preferentially expressed in photoreceptors. While adeno-associated virus (AAV)-mediated gene transfer can correct retinal pigment epithelium (RPE) defects in animal models, approaches for the correction of photoreceptor-specific diseases are less efficient. We evaluated the ability of novel AAV serotypes (AAV2/7, AAV2/8, AAV2/9, AAV2rh.43, AAV2rh.64R1, and AAV2hu.29R) in combination with constitutive or photoreceptor-specific promoters to improve photoreceptor transduction, a limiting step in photoreceptor rescue. Based on a qualitative analysis, all AAV serotypes tested efficiently transduce the RPE as well as ro...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
Retinal gene therapy with adeno-associated viral (AAV) vectors is safe and effective in humans. Howe...
Retinal gene transfer with adeno-associated viral (AAV) vectors holds great promise for the treatmen...
Severe inherited retinal diseases, such as retinitis pigmentosa and Leber congenital amaurosis, are ...
Inherited retinal degenerations are genetically heterogeneous conditions affecting roughly 1:3000 pe...
Recent success in clinical trials supports the use of adeno-associated viral (AAV) vectors for gene ...
Recombinant adeno-associated viral (AAV) vectors are known to safely and efficiently transduce the r...
Inherited retinal degenerations, effecting about 1:3000 people, have historically been challenging t...
Adeno-associated viral vectors are showing great promise as gene therapy vectors for a wide range of...
As gene therapies for various forms of retinal degeneration progress toward human clinical trial, it...
Retinal gene therapy with adeno-associated viral (AAV) vectors is safe and effective in humans. Howe...
Current retinal gene therapies using adeno-associated viral (AAV) vectors are limited in their effic...
LuxturnaTM is a retinal gene therapy treatment for an inherited retinal degeneration (IRD) caused by...
Leber congenital amaurosis is a group of inherited retinal dystrophies that cause severe sight impai...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
Retinal gene therapy with adeno-associated viral (AAV) vectors is safe and effective in humans. Howe...
Retinal gene transfer with adeno-associated viral (AAV) vectors holds great promise for the treatmen...
Severe inherited retinal diseases, such as retinitis pigmentosa and Leber congenital amaurosis, are ...
Inherited retinal degenerations are genetically heterogeneous conditions affecting roughly 1:3000 pe...
Recent success in clinical trials supports the use of adeno-associated viral (AAV) vectors for gene ...
Recombinant adeno-associated viral (AAV) vectors are known to safely and efficiently transduce the r...
Inherited retinal degenerations, effecting about 1:3000 people, have historically been challenging t...
Adeno-associated viral vectors are showing great promise as gene therapy vectors for a wide range of...
As gene therapies for various forms of retinal degeneration progress toward human clinical trial, it...
Retinal gene therapy with adeno-associated viral (AAV) vectors is safe and effective in humans. Howe...
Current retinal gene therapies using adeno-associated viral (AAV) vectors are limited in their effic...
LuxturnaTM is a retinal gene therapy treatment for an inherited retinal degeneration (IRD) caused by...
Leber congenital amaurosis is a group of inherited retinal dystrophies that cause severe sight impai...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
Retinal gene therapy with adeno-associated viral (AAV) vectors is safe and effective in humans. Howe...
Retinal gene transfer with adeno-associated viral (AAV) vectors holds great promise for the treatmen...